Recombinant Glycoprotein Production

<p>Platforms for Recombinant Therapeutic Glycoprotein Production.- Uncovering Innovation Features and Emerging Technologies in Molecular Biology through Patent Analysis.- Production of Full-length Antibody by Pichia Pastoris.- Human cells as Platform to Produce Gamma-Carboxylated Proteins.- Production of Recombinant Factor VIII in Human Cell Lines.- Strategies to Suspension Serum-Free Adaptation of Mammalian Cell Lines for Recombinant Glycoprotein Production.- Production of Recombinant Rabies Virus Glycoprotein by Insect Cells in a Single Use Fixed-bed Bioreactor.- Cell-Free Production of Protein Biologics within 24 hours.- Demonstration-Scale High-Cell-Density Fermentation of Pichia Pastoris.- Large Scale Transient Transfection of Suspension Mammalian Cells for VLP Production.- Bioreactor-Based Production of Glycoproteins in Plant Cell Suspension Cultures.- Fed-Batch CHO Cell Culture for Lab-Scale Antibody Production.- Strategies to Develop Therapeutic N- and O-Hyperglycosylated Proteins.- Expression of Glycosylated Proteins in Bacterial System and Purification by Affinity Chromatography.- Purification Methods for Recombinant Factor VIII Expressed in Human Liver SK-Hep Cells.- Purification Method for Recombinant hG-CSF by Affinity Chromatography.- Microplate-Based Method for High-Throughput Screening (HTS) of Chromatographic Conditions Studies for Recombinant Protein Purification.- Purification and Auto Activation Method for Recombinant Coagulation Factor VII.- Preparation of Immunoliposomes by Direct Coupling of Antibodies Based on a Thioether Bond.- Polyester-Based Nanoparticles for the Encapsulation of Monoclonal Antibodies.- Polyester-Based Nanoparticles for Delivery of Therapeutic Proteins.- Quantification of Coagulation Factor VIII by Selective Reaction Monitoring.</p><p></p>